{
}
The global cancer immunotherapy market is projected to reach $135.2 billion in 2024, growing at a CAGR of 9.8% to $236.9 billion by 2030, driven by rising cancer prevalence and demand for effective treatments. North America leads the market, while Asia-Pacific is the fastest-growing region. Monoclonal antibodies dominate the product segment, with lung cancer applications holding the largest market share, and breast cancer expected to grow the fastest.
Priya Pandey, a biotechnology graduate, excels in creating engaging content across various industries, including healthcare and technology. Coherent Market Insights offers comprehensive market intelligence and consulting services, providing detailed reports on sectors like food and beverages and pharmaceuticals, with insights into market dynamics and competitive strategies. The latest report on the Lateral Flow Assay Market forecasts trends and growth from 2024 to 2031, analyzing consumer behavior and regulatory factors while highlighting key players and emerging opportunities.
The global clinical biomarkers market, valued at $25.02 billion in 2023, is projected to reach $47.25 billion by 2031, growing at a CAGR of 8.54%. This growth is driven by rising cancer cases and advancements in diagnostic technologies, despite challenges like high costs and reimbursement issues. Key players include Roche, Abbott, and Johnson & Johnson, with significant developments in biomarker testing for various diseases.
The Breakthrough Therapies Market is projected to grow from USD 150.6 billion in 2024 to USD 287.5 billion by 2029, achieving a CAGR of 13.80%. The report analyzes risks, benefits, and competitive strategies related to breakthrough therapy designation across various therapeutic areas, including oncology and rare diseases, while profiling key market players and trends.
The global Precision Medicine market, valued at $89.9 billion in 2023, is projected to reach $161.1 billion by 2030, growing at a CAGR of 8.7%. Key drivers include advancements in genomic sequencing, rising chronic disease prevalence, and increased investment in targeted therapies, particularly in oncology. The integration of AI and machine learning is further enhancing personalized treatment approaches, paving the way for more effective healthcare solutions.
Data Bridge Market Research has successfully catered to over 40% of Fortune 500 companies globally, boasting a clientele of more than 5,000 and a remarkable 99.9% client satisfaction rate. The firm specializes in market research and consulting, focusing on uncovering opportunities and providing solutions to complex business challenges. In the radiology sector, key players like Siemens Healthineers, GE Healthcare, and Philips Healthcare are driving innovation and enhancing diagnostic capabilities through advanced technologies. The report highlights market trends, growth potential, and competitive analysis across various regions, emphasizing the importance of informed decision-making for B2B companies.
The intratumor cancer therapies market, valued at $151.5 million in 2022, is projected to grow at a CAGR of 9.9% from 2023 to 2030, driven by advances in immunotherapy and personalized medicine. Monoclonal antibodies are leading the technology segment, while lung cancer remains the primary application area. North America is the dominant market, fueled by rising cancer prevalence and increased awareness of innovative treatment options.
The global diabetic retinopathy devices market, valued at USD 12.47 billion in 2022, is projected to grow at a robust CAGR of around 30% through 2030, driven by rising diabetes cases and an aging population. Non-proliferative diabetic retinopathy is expected to dominate, while North America will lead regionally, with significant contributions from the APAC region due to its large diabetic population. Key players include F. Hoffmann-La Roche, Novartis, and Regeneron, focusing on innovative treatments and technologies.
The difelikephalin drug market, valued at $XX billion in 2022, is projected to grow at a CAGR of 6.5% from 2023 to 2030, driven by increased product launches and rising cases of pruritus linked to chronic kidney disease. North America is expected to dominate the market, with major players including F. Hoffmann-La Roche Ltd and Regeneron Pharmaceuticals Inc. The online distribution segment is anticipated to experience significant growth due to the rise of digital media and social media marketing.
The global autism spectrum disorder market is valued at approximately $30 billion in 2023, with a projected CAGR of 4% from 2024 to 2032, driven by improved diagnostic tools and early intervention strategies. North America is expected to dominate the market, while the Asia-Pacific region is anticipated to grow rapidly due to increased awareness and healthcare investments. The antipsychotic drug segment leads the market, addressing severe behavioral symptoms and enhancing patients' quality of life.
F. Hoffmann-La Roche Ltd.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
global cancer immunotherapy market projected to reach 236.9 billion by 2030
United States Dollar
GSK plc
Bristol-Myers Squibb Company
Bayer AG
Eli Lilly and Company
Pfizer Inc.
Merck & Co., Inc.
Novartis AG
Immunocore Holdings plc
AstraZeneca PLC
Amgen Inc.
F. Hoffmann-La Roche Ltd.
IND
FRA
ARG
CAN
ESP
USA
BRA
CHN
MEX
DEU
ITA
JPN
GBR
KOR
Show more
10:06 10.01.2025
lateral flow assay market analysis trends and growth opportunities 2024 to 2031
United States Dollar
QuidelOrtho Corporation
Hologic Inc
Thermo Fisher Scientific Inc.
QIAGEN NV
Siemens AG
Abcam plc
PerkinElmer Inc
Danaher Corporation
Eiken Chemical Co., Ltd.
Becton, Dickinson and Company
Merck KGaA
Bio-Rad Laboratories Inc
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Biomerieux SA
FRA
ARG
NZL
CAN
TUR
SAU
ARE
USA
RUS
IND
AUS
ESP
GBR
SGP
BRA
IRN
CHN
DEU
MEX
ITA
JPN
Priya Pandey
Show more
09:06 10.01.2025
global clinical biomarkers market projected to reach 47 billion by 2031
Eurofins Scientific S.E. A
PerkinElmer Inc
Johnson & Johnson Services Inc.
Bio-Rad Laboratories, Inc.
Qiagen N.V.
Merck KGaA
Thermo Fisher Scientific Inc.
General Electric Co
Siemens Healthineers AG
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
USA
Show more
08:45 16.12.2024
breakthrough therapy designation market projected to reach 287.5 billion by 2029
United States Dollar
Bristol-Myers Squibb Co
Merck & Co., Inc.
AstraZeneca PLC
F. Hoffmann-La Roche Ltd.
Novartis AG
Show more
17:02 13.12.2024
global precision medicine market projected to reach 161 billion by 2030
SIEMENS HEALTHINEERS
Medtronic plc
Quest Diagnostics Incorporated
Genesis Healthcare, Inc.
Abbott Laboratories
Myriad Genetics Inc
BIOGEN
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
DEU
CAN
CHN
JPN
USA
Show more
14:51 13.12.2024
global radiology market trends and key players shaping healthcare delivery
United States Dollar
General Electric Co
Siemens Energy AG
Koninklijke Philips N.V.
Agfa-Gevaert NV
Canon Medical Systems Corporation
Hitachi Ltd
Carestream Health Inc.
Esaote S.p.A.
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
FUJIFILM Holdings Corporation
Cerner Corporation
Samsung Biologics Co.,Ltd.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Planmed Oy
CurveBeam AI Limited
Shimadzu Corporation
Allscripts Healthcare LLC
USA
GBR
NLD
BEL
JPN
ITA
CHE
FIN
KOR
CHN
BRA
ARG
COL
DEU
FRA
RUS
IND
SAU
ARE
EGY
NGA
Show more
12:56 12.11.2024
growth of intratumor cancer therapies market driven by innovative treatments and technologies
United States Dollar
Eli Lilly and Company
AbbVie Inc.
AstraZeneca PLC
Amgen Inc.
Novartis AG
Merck & Co., Inc.
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Bayer AG
USA
Show more
06:23 04.11.2024
diabetic retinopathy market poised for significant growth driven by rising diabetes cases
Indian Rupee
Pakistani Rupee
Chinese Yuan
United States Dollar
Regeneron Pharmaceuticals, Inc.
Sanofi
Coherus BioSciences, Inc.
Novartis AG
Bayer AG
Kodiak Sciences Inc.
HANLIM PHARM.CO.LTD
Intas Pharmaceuticals Ltd.
SUN Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche Ltd.
PAK
CHN
IND
Bayer
Regeneron Pharmaceuticals
Sun Yat-Sen
Novartis
F. Hoffmann-La Roche
Show more
14:04 26.10.2024
difelikephalin drug market poised for growth driven by chronic kidney disease treatments
United States Dollar
Vifor Pharma Management Ltd
Amgen Inc.
Biogen Inc.
Entia
Benevolent IA
IDEXX
F. Hoffmann-La Roche Ltd.
Regeneron Pharmaceuticals, Inc.
AstraZeneca PLC
VENOSTENT, INC
USA
CHN
Show more
16:20 25.10.2024
global autism spectrum disorder market projected to reach 30 billion by 2023
United States Dollar
Novartis AG
PaxMedica, Inc.
Otsuka Pharmaceutical Co. Ltd.
Q BioMed Inc.
F. Hoffmann-La Roche Ltd.
USA
Yamo Pharmaceuticals
Q BioMed Inc
F. Hoffmann-La Roche
PaxMedica
Otsuka Pharmaceutical Co.
Show more
00:51 23.10.2024
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Industry Mergers & Acquisitions
Finance Mergers & Acquisitions
Domestic Politics
Banking Regulations
Global Financial Events
Retail and Consumer Goods
CEO Changes
Government Policies
Workplace Trends
Elections & Campaigns
Market Analysis and Predictions
Global Trade Developments
Central Bank Actions
Startups & Entrepreneurship
Government Economic Policies
Supply Chain Management
Hedge Funds & Private Equity
Countries:
Companies:
Tesla, Inc.
UniCredit S.p.A.
Banco BPM S.p.A.
Deutsche Bank Money Market PP
JPMorgan Chase & Co.
Barclays PLC
Apple Inc.
Credit Suisse Strategic Income I
CREDIT AGRICOLE
SpaceXCoin USD
Lloyds Banking Group plc
BNP Paribas SA
Amazon.com, Inc.
The Goldman Sachs Group, Inc.
UBS Group AG
Credit Agricole
Banco Santander, S.A.
Reinsurance Group of America, Incorporated
Google Inc.
Amundi S.A.
Currencies:
United States Dollar
Euro
British Pound Sterling
Swiss Franc
Chinese Yuan
Indian Rupee
Japanese Yen
South Korean Won
Offshore Chinese Yuan
Hong Kong Dollar
Norwegian Krone
Filipino Peso
Canadian Dollar
Singapore Dollar
Australian Dollar
Danish Krone
Swedish Krona
Mexican Peso
New Taiwan Dollar
Vietnamese Đồng
People: